Mammogram: Breast Cancer Screening Guide
📊 Quick facts about mammography screening
💡 The most important things you need to know
- Early detection saves lives: Mammography can detect breast cancer before you can feel a lump, improving survival rates significantly
- Screening recommendations: Most guidelines recommend regular mammograms starting between ages 40-50, continuing until at least age 74
- Brief discomfort is normal: The breast compression during mammography lasts only a few seconds and is necessary for clear images
- Low radiation exposure: Modern mammography uses very low radiation doses, and the benefits far outweigh the minimal risks
- Callback doesn't mean cancer: About 10% of women are called back for additional imaging, but most abnormalities are not cancer
- Continue self-exams: Regular breast self-examination complements but does not replace mammography screening
What Is a Mammogram and How Does It Work?
A mammogram is a low-dose X-ray examination of the breast tissue that can detect breast cancer and other abnormalities. During the procedure, each breast is compressed between two plates while images are taken from different angles. Mammography can identify tumors that are too small to feel, often years before symptoms appear.
Mammography remains the gold standard for breast cancer screening worldwide, supported by decades of research demonstrating its effectiveness in reducing mortality. The procedure works by using low-energy X-rays to create detailed images of the internal structure of the breast, allowing radiologists to identify abnormalities such as calcifications, masses, or architectural distortions that may indicate the presence of cancer or precancerous changes.
The technology has evolved significantly since its introduction in the 1960s. Modern digital mammography provides higher image quality with lower radiation doses compared to traditional film mammography. Additionally, many centers now offer 3D mammography (tomosynthesis), which takes multiple images from different angles to create a three-dimensional view of the breast, improving detection rates particularly in women with dense breast tissue.
Breast cancer is one of the most common cancers affecting women globally, with approximately 2.3 million new cases diagnosed annually according to the World Health Organization. However, when detected early through screening, the five-year survival rate for localized breast cancer exceeds 99%. This dramatic difference in outcomes underscores the critical importance of regular mammography screening.
Types of Mammography
There are two main categories of mammography, each serving different purposes in breast health management. Understanding the distinction helps patients know what to expect and when each type is appropriate.
Screening mammography is performed on women without symptoms as a preventive measure to detect breast cancer early. This is the type of mammogram offered through organized screening programs and is typically performed every one to two years depending on age and risk factors. Screening mammograms usually take two images of each breast from different angles.
Diagnostic mammography is ordered when a woman has symptoms such as a breast lump, nipple discharge, skin changes, or pain, or when a screening mammogram reveals an abnormality requiring further evaluation. Diagnostic mammography is more comprehensive, with additional views and magnification as needed to investigate specific areas of concern.
How Digital and 3D Mammography Differ
Digital mammography (also called full-field digital mammography or FFDM) replaced film-based systems in most medical facilities. Digital images can be enhanced, magnified, and stored electronically, improving diagnostic accuracy and facilitating comparison with previous examinations. The images can also be transmitted instantly to specialists for remote consultation.
Three-dimensional mammography, known as digital breast tomosynthesis (DBT), represents the most significant advancement in mammography technology in recent years. During tomosynthesis, the X-ray tube moves in an arc over the breast, taking multiple images that are reconstructed into thin slices. This technology reduces the overlap of breast tissue that can obscure cancers or create false alarms in traditional 2D imaging. Studies show that 3D mammography detects 20-65% more invasive cancers compared to digital mammography alone, while also reducing false-positive callbacks.
Who Should Get Mammograms and When?
Most international guidelines recommend that women at average risk begin regular mammography screening between ages 40 and 50, with screenings every one to two years until at least age 74. Women with higher risk factors, such as family history of breast cancer or genetic mutations like BRCA1/BRCA2, may need to start earlier and may benefit from additional screening methods.
Determining when to begin mammography screening and how often to have examinations involves balancing the benefits of early cancer detection against the potential harms of false-positive results and overdiagnosis. Different medical organizations have slightly different recommendations based on their interpretation of the evidence, but all agree that regular screening mammography saves lives.
The American Cancer Society recommends that women with average risk should have the choice to begin annual mammography at age 40 and should begin annual screening by age 45. At age 55, women can transition to biennial (every two years) screening or continue annual screening. The US Preventive Services Task Force (USPSTF) recommends biennial screening from ages 50 to 74, with the decision to start screening before age 50 being an individual one. The European Guidelines on Breast Cancer Screening generally recommend organized screening programs for women aged 50-69, with some countries extending to ages 45-74.
These varying recommendations reflect the ongoing scientific discussion about the optimal balance between benefits and harms at different ages. For women in their 40s, the absolute benefit of screening is smaller because breast cancer is less common in this age group, while the rate of false-positive results is higher due to denser breast tissue. However, cancers that do occur in younger women tend to be more aggressive, making early detection particularly valuable.
High-Risk Screening Guidelines
Women with certain risk factors may benefit from earlier, more frequent screening and additional imaging modalities. The following factors significantly increase breast cancer risk and typically warrant enhanced screening protocols:
- BRCA1 or BRCA2 gene mutations: Women with these hereditary mutations have a 45-72% lifetime risk of breast cancer and typically begin screening at age 25-30 with annual MRI and mammography
- First-degree relatives with breast cancer: Having a mother, sister, or daughter with breast cancer approximately doubles your risk, especially if diagnosed before age 50
- Previous chest radiation therapy: Women who received radiation to the chest area for conditions like Hodgkin lymphoma before age 30 have increased risk and benefit from earlier screening
- Personal history of breast cancer or certain precancerous conditions: Previous diagnosis warrants more intensive surveillance
- Very dense breast tissue: Extremely dense breasts increase cancer risk and may warrant additional screening with ultrasound or MRI
For high-risk women, supplemental screening with breast MRI may be recommended in addition to mammography. MRI is particularly effective at detecting cancers in dense breast tissue and can identify tumors not visible on mammography. However, MRI has a higher false-positive rate and is more expensive, so it is generally reserved for women whose elevated risk justifies these considerations.
Screening After Age 74
Most organized screening programs stop inviting women for screening at age 74-75, primarily because there is limited research data on the benefits and harms of screening in this age group. However, this does not mean screening should automatically stop at this age. The decision to continue mammography should be based on individual health status, life expectancy, and personal preferences.
Women in good health with a life expectancy of 10 years or more may continue to benefit from screening, as breast cancer risk increases with age. Conversely, women with serious health conditions that limit life expectancy may reasonably choose to discontinue screening. This decision should be made through shared decision-making with a healthcare provider, considering the individual's values and circumstances.
Mammography screening programs generally target individuals who were assigned female at birth and are within the specified age range. Transgender individuals should discuss screening recommendations with their healthcare providers based on their individual circumstances, including hormone use and any breast tissue present.
How Is a Mammogram Performed?
During a mammogram, you will undress from the waist up and stand in front of the mammography machine. A technologist positions each breast on a flat plate, then a clear plastic paddle compresses the breast for a few seconds while images are taken. Two to three images are typically taken of each breast from different angles. The entire appointment usually takes 15-30 minutes.
Understanding what to expect during a mammogram can help reduce anxiety and ensure you're properly prepared for the examination. The mammography procedure has been refined over decades to maximize diagnostic quality while minimizing discomfort and radiation exposure.
When you arrive for your appointment, you will be asked to undress from the waist up and put on a gown that opens in the front. You should remove any necklaces or other jewelry that could interfere with the imaging. The technologist (usually called a mammography technologist or radiographer) will first ask you some questions about your medical history, any breast symptoms, and whether you're pregnant or breastfeeding.
For the examination itself, you will stand in front of the mammography machine. The technologist will position one breast at a time on a flat support plate. A clear plastic paddle then presses down on the breast to spread the tissue and create an even thickness. This compression is essential for several reasons: it separates overlapping breast tissue so abnormalities are more visible, it holds the breast still to prevent motion blur, and it allows a lower radiation dose to be used.
Breast Compression During the Exam
The compression phase is the part of mammography that many women find uncomfortable. The sensation is often described as pressure, tightness, or pinching. For some women, particularly those with sensitive breasts, it can be painful. However, the compression typically lasts only 10-15 seconds for each image, and most women can tolerate it without significant difficulty.
Several factors can affect comfort during mammography. Breasts are often more sensitive during certain times of the menstrual cycle, particularly in the week before menstruation. Scheduling your mammogram for the week after your period ends, when breasts are typically less tender, can help reduce discomfort. If you have particularly sensitive breasts, you might consider taking an over-the-counter pain reliever such as ibuprofen or acetaminophen about an hour before your appointment.
Communication with the technologist is important. If the compression feels too painful, let them know. While adequate compression is necessary for good image quality, technologists are trained to apply the minimum pressure needed and can make adjustments if you're experiencing significant pain.
What Happens After the Images Are Taken
After the imaging is complete, you can get dressed. The images are reviewed by a radiologist, a physician specially trained in interpreting medical images. In some cases, the radiologist may review the images while you're still at the facility and request additional views if needed. More commonly, results are provided within one to two weeks.
After the examination, you may notice some temporary redness or tenderness in the breast from the compression. This typically resolves within a day or so. You can immediately resume normal activities after a mammogram—there are no restrictions or recovery time needed.
How Should I Prepare for My Mammogram?
To prepare for a mammogram, avoid using deodorant, antiperspirant, powder, lotion, or perfume on your chest and underarm area on the day of the exam. Wear a two-piece outfit so you only need to remove your top. Bring any previous mammogram images if they were done at a different facility. Schedule your appointment for the week after your menstrual period if your breasts are typically tender.
Proper preparation can help ensure your mammogram images are of the highest quality and that your experience is as comfortable as possible. While a mammogram doesn't require extensive preparation, following these guidelines can make a significant difference.
The most important preparation step is avoiding certain products on the day of your mammogram. Deodorants, antiperspirants, powders, lotions, creams, and perfumes can contain particles that appear as white spots on the X-ray images. These artifacts can mimic or obscure calcifications, potentially leading to incorrect interpretations. Make sure to clean your underarm area and avoid applying any products to your chest, armpits, or under your breasts before your appointment.
Wearing appropriate clothing makes the process smoother. A two-piece outfit allows you to remove only your top while keeping your pants or skirt on. Avoid wearing a dress or jumpsuit that would require you to undress completely. Skip necklaces and other jewelry around your neck area, as these will need to be removed.
Information to Bring to Your Appointment
If you've had mammograms at a different facility, try to obtain those images or have them transferred before your appointment. Comparing current images to previous ones helps radiologists identify new or changing abnormalities. Most facilities can arrange image transfers, but this process may take several days.
Be prepared to provide information about your medical history, including:
- Any current breast symptoms, such as lumps, pain, or nipple discharge
- History of breast biopsies or surgeries
- Whether you have breast implants
- Use of hormone therapy or hormonal contraceptives
- Family history of breast or ovarian cancer
- Whether you might be pregnant or are breastfeeding
If you are breastfeeding, you can still have a mammogram, but scheduling it shortly after feeding or pumping—when breasts contain less milk—can improve image quality and comfort. If you have breast implants, inform the scheduling staff when making your appointment, as the examination may take longer and require special techniques.
What Do Mammogram Results Mean?
Mammogram results are typically reported using the BI-RADS (Breast Imaging Reporting and Data System) scale from 0 to 6. A score of 1 (negative) or 2 (benign findings) means no concerning abnormalities were found. A score of 0 means additional imaging is needed. Scores of 3-5 indicate varying levels of suspicion for malignancy, while 6 indicates known cancer. Most women receive normal results.
Understanding how mammogram results are reported can help reduce anxiety when waiting for results and provide context for any follow-up recommendations. The BI-RADS system, developed by the American College of Radiology, provides standardized terminology for mammography interpretation.
Results are typically available within one to two weeks after your mammogram. You will receive written notification of your results, as required by law in many countries. If your mammogram shows an abnormality requiring prompt attention, you may be contacted sooner by phone or letter asking you to return for additional imaging.
BI-RADS Categories Explained
Category 0: Incomplete—Additional imaging needed. This means the radiologist needs more information to make a complete assessment. You may be called back for additional mammography views, ultrasound, or other imaging. This is common and does not mean you have cancer. About 10% of screening mammograms result in a callback, but the vast majority of these turn out to be benign.
Category 1: Negative. The mammogram shows no abnormalities. Breast tissue appears normal and symmetric, with no masses, calcifications, or areas of distortion. You should continue routine screening at the recommended interval.
Category 2: Benign finding. A clearly benign abnormality is present, such as calcified fibroadenomas, breast cysts, fat-containing lesions, or other findings that are definitively not cancer. While a finding is described, it requires no further action beyond routine screening.
Category 3: Probably benign. A finding has less than 2% chance of being cancer. Short-term follow-up (typically at 6 months) is usually recommended to confirm stability. If the finding remains unchanged over 2-3 years of follow-up, it can be downgraded to benign.
Category 4: Suspicious abnormality. The finding has a 2-95% likelihood of being cancer. Biopsy is recommended. This category is often subdivided into 4A (low suspicion, 2-10%), 4B (moderate suspicion, 10-50%), and 4C (high suspicion, 50-95%).
Category 5: Highly suggestive of malignancy. The finding has greater than 95% likelihood of being cancer. Biopsy and appropriate treatment planning are recommended.
Category 6: Known biopsy-proven malignancy. This is used when a biopsy has already confirmed cancer, typically for imaging to monitor response to treatment or plan surgery.
| Category | Assessment | Cancer Likelihood | Recommended Action |
|---|---|---|---|
| 0 | Incomplete | N/A | Additional imaging needed |
| 1 | Negative | Essentially 0% | Routine screening |
| 2 | Benign | Essentially 0% | Routine screening |
| 3 | Probably benign | <2% | Short-term follow-up |
| 4 | Suspicious | 2-95% | Biopsy recommended |
| 5 | Highly suggestive | >95% | Biopsy and treatment planning |
| 6 | Known cancer | 100% | Treatment monitoring |
What If I'm Called Back for More Tests?
Receiving a callback for additional imaging can cause significant anxiety, but it's important to understand that most callbacks do not result in a cancer diagnosis. Additional imaging is often needed simply because an area was not clearly visualized on the initial images, or because a benign finding needs to be better characterized.
When called back, you may have additional mammography views focusing on the area of concern, including spot compression or magnification views. You may also have a breast ultrasound, which uses sound waves to distinguish solid masses from fluid-filled cysts. In some cases, breast MRI may be recommended.
Of women who are called back for additional imaging after a screening mammogram, about 80-90% will have benign findings or normal results. Only about 0.5% of all screening mammograms ultimately result in a cancer diagnosis. While waiting for follow-up results can be stressful, the purpose of this careful evaluation is to ensure that any cancer is found and treated early while avoiding unnecessary biopsies of benign findings.
What Are the Benefits and Risks of Mammography?
The primary benefit of mammography screening is reduced breast cancer mortality, with studies showing a 20-40% reduction in deaths among screened women aged 50-74. Potential harms include false-positive results leading to additional testing and anxiety, overdiagnosis of cancers that would never cause harm, and the small radiation exposure. For most women in the recommended screening age range, the benefits outweigh the risks.
Making an informed decision about mammography screening requires understanding both the benefits it offers and the potential downsides. The evidence supporting mammography's life-saving potential is strong, but like any medical intervention, it is not without limitations and potential harms.
Benefits of Mammography Screening
The most significant benefit of mammography is the reduction in breast cancer deaths. Large randomized controlled trials and decades of population-based screening programs have demonstrated that regular mammography screening reduces breast cancer mortality by approximately 20-40% in women who participate. For every 1,000 women screened regularly for 10 years starting at age 50, approximately 2-3 breast cancer deaths are prevented.
Beyond mortality reduction, mammography offers other important benefits. Cancers detected through screening tend to be smaller and less likely to have spread to lymph nodes compared to cancers detected after symptoms appear. This often allows for less aggressive treatment—for example, lumpectomy instead of mastectomy, or avoiding chemotherapy. The physical, emotional, and financial burden of treating advanced cancer is substantially greater than treating early-stage disease.
Early detection also provides peace of mind for the majority of women who receive normal results. Regular screening can reassure women that no cancer is currently detectable, though it's important to understand that mammography does not prevent breast cancer—it detects existing cancer.
Potential Risks and Limitations
False-positive results occur when mammography identifies an abnormality that turns out not to be cancer after additional testing. The cumulative probability of experiencing at least one false-positive result over 10 years of annual screening is approximately 50-60%. These false alarms lead to additional imaging, sometimes biopsies, and can cause significant anxiety. While the long-term psychological impact of false-positive results appears to be minimal for most women, the short-term distress and inconvenience are real considerations.
Overdiagnosis refers to the detection of cancers that would never have caused harm if left undetected—either because they would grow so slowly that the woman would die of other causes first, or because they would never progress. Estimates of overdiagnosis vary widely, from about 1% to 30% of screen-detected cancers. Overdiagnosed cancers are treated just like any other breast cancer, exposing women to potential harms of treatment (surgery, radiation, hormone therapy) without corresponding benefit.
Radiation exposure from mammography is very low. A standard two-view mammogram delivers approximately 0.4 millisieverts (mSv) of radiation, equivalent to about 7 weeks of natural background radiation. The risk of inducing a fatal breast cancer from mammography radiation is estimated at approximately 1-5 per 100,000 women screened. This risk is far outweighed by the mortality benefit of screening.
False-negative results occur when mammography fails to detect an existing cancer. No screening test is perfect, and mammography misses approximately 10-20% of breast cancers, particularly in women with dense breast tissue. This is why it's important to report any new breast symptoms to your healthcare provider even if your most recent mammogram was normal.
You should not wait for your next scheduled mammogram if you notice any of these changes in your breasts: a new lump or mass, skin dimpling or puckering, nipple changes or discharge, redness or warmth, persistent pain in one area, or any other unusual change. These symptoms warrant prompt medical evaluation.
What Are Dense Breasts and Why Do They Matter?
Breast density refers to the proportion of fibroglandular tissue compared to fatty tissue in the breast, as seen on mammography. About 40-50% of women have dense breasts. Dense breast tissue appears white on mammograms—the same color as tumors—making cancers harder to detect. Women with dense breasts also have a higher risk of developing breast cancer and may benefit from supplemental screening with ultrasound or MRI.
Breast density has become an increasingly important topic in breast cancer screening, as research has revealed both its impact on mammography's effectiveness and its role as an independent risk factor for breast cancer. Many regions now require that women be informed about their breast density after mammography.
Breasts are composed of three types of tissue: fibrous connective tissue, glandular tissue (lobules and ducts), and fatty tissue. On a mammogram, fatty tissue appears dark while fibroglandular tissue appears white. Dense breasts have more fibroglandular tissue relative to fatty tissue. Since both dense breast tissue and tumors appear white on mammograms, cancers can be obscured or "hidden" in dense tissue, similar to trying to find a snowball in a snowstorm.
Categories of Breast Density
Breast density is classified into four categories on mammography:
- Category A: Almost entirely fatty. The breasts are almost entirely composed of fat with very little dense tissue. Mammography is highly effective at detecting abnormalities.
- Category B: Scattered areas of fibroglandular density. The breasts have scattered areas of dense tissue but most is fatty. Mammography works well in this category.
- Category C: Heterogeneously dense. The breasts have many areas of dense tissue that may obscure small masses. This is considered "dense."
- Category D: Extremely dense. The breasts are almost entirely dense tissue. Small masses may be difficult to detect on mammography. This is also considered "dense."
Women in categories C and D (approximately 40-50% of all women) are considered to have "dense breasts." Breast density is determined by the radiologist reading your mammogram and is included in your results letter in many regions.
Supplemental Screening for Dense Breasts
For women with dense breasts, several supplemental screening options may help detect cancers that mammography alone might miss. Breast ultrasound uses sound waves to image the breast and can find cancers not visible on mammography. Studies show ultrasound can detect an additional 2-4 cancers per 1,000 women with dense breasts and negative mammograms. However, ultrasound also has a higher false-positive rate.
Breast MRI is the most sensitive imaging method for breast cancer detection and can find cancers missed by both mammography and ultrasound. However, MRI is expensive, time-consuming, and has a high false-positive rate, so it is typically reserved for women at high risk of breast cancer.
Contrast-enhanced mammography (CEM) is a newer technique that combines mammography with an injected contrast agent, similar to MRI, and may offer improved detection in dense breasts at lower cost than MRI.
If you have dense breasts, discuss with your healthcare provider whether supplemental screening is appropriate for you based on your overall risk profile.
Mammography in Special Situations
Mammography can be performed safely in most situations, including pregnancy (with shielding), breastfeeding, and in women with breast implants using specialized techniques. The examination approach may be modified to accommodate specific circumstances while still providing diagnostic quality images.
Mammography During Pregnancy
While routine screening mammography is not typically performed during pregnancy, diagnostic mammography can be done safely when there is a clinical indication such as a concerning breast lump. The radiation dose from mammography is very low and directed at the breast, not the abdomen. Lead shielding of the abdomen can be used to further minimize fetal radiation exposure. The decision to perform mammography during pregnancy is based on careful consideration of the clinical situation, balancing potential risks against the importance of evaluating a breast abnormality.
Mammography While Breastfeeding
Breastfeeding does not prevent you from having a mammogram, though it may make interpretation more challenging due to the increased density of lactating breast tissue. To optimize image quality and comfort, try to schedule your mammogram shortly after feeding or pumping, when breasts contain less milk. Empty the breasts as thoroughly as possible before the exam. It is not necessary to "pump and dump" after mammography—the small radiation exposure does not affect breast milk.
Mammography with Breast Implants
Women with breast implants can and should continue regular mammography screening. However, the examination requires modified techniques. Standard compression may not be applied over implants, and special views called "implant displacement" or "Eklund" views are taken, where the implant is pushed back against the chest wall while the breast tissue is pulled forward for imaging.
Let the scheduling staff know you have implants when making your appointment, as the examination takes longer (typically 30-45 minutes instead of 15-20 minutes). Also inform the technologist about the type of implants you have and when they were placed. If your implants were placed less than six months ago, consult with your surgeon about the timing of mammography.
Modern breast implants approved for medical use are designed to withstand the compression of mammography without rupturing. Implant rupture during mammography is extremely rare.
After Previous Breast Cancer
Women who have been treated for breast cancer typically require ongoing surveillance mammography, though the specific protocol varies based on the type of treatment received. After breast-conserving surgery (lumpectomy), annual mammography of both breasts is recommended. After mastectomy, annual mammography of the remaining breast is recommended. Some centers may perform additional imaging of reconstructed breasts depending on the type of reconstruction.
When Should You See a Doctor About Breast Symptoms?
You should contact your healthcare provider promptly if you notice a new lump or thickening in your breast or armpit, changes in breast size or shape, nipple discharge (especially if bloody), nipple inversion or changes in direction, skin changes such as dimpling, puckering, or redness, or persistent breast pain in one area. Don't wait for your next scheduled mammogram if you have symptoms.
While mammography is an essential screening tool for detecting breast cancer before symptoms appear, it does not replace attention to changes in your own body. Being familiar with how your breasts normally look and feel helps you recognize when something has changed. Breast self-awareness—regular observation and feeling of your breasts—complements but does not replace mammography screening.
The following signs and symptoms warrant prompt medical evaluation:
- A new lump or mass: Any new lump in the breast or armpit (axilla) should be evaluated, even if your recent mammogram was normal. Not all breast cancers are visible on mammography.
- Changes in breast size or shape: Unexplained swelling or shrinkage of one breast, or asymmetric changes in breast contour
- Nipple changes: Inversion (turning inward) of a nipple that was previously outward, crusting or scaling of the nipple, or changes in nipple direction
- Nipple discharge: Fluid from the nipple, particularly if bloody, occurring spontaneously (without squeezing), or from only one breast
- Skin changes: Dimpling, puckering, or an "orange peel" texture (peau d'orange), redness, warmth, or thickening of the breast skin
- Persistent localized pain: While most breast pain is not caused by cancer, pain that is localized to one area and doesn't go away should be evaluated
Many of these symptoms have benign causes, but they should still be evaluated to rule out cancer or other conditions requiring treatment. If you notice any of these changes, contact your primary care provider, gynecologist, or a breast health center to arrange an examination.
In case of a medical emergency, contact your local emergency services immediately. Find emergency contact numbers for your country.
Frequently Asked Questions About Mammography
Most international guidelines recommend starting regular mammography screening between ages 40 and 50 for women at average risk. The American Cancer Society recommends the option to begin at age 40, with annual mammograms by age 45. The US Preventive Services Task Force recommends starting at age 50. Women with higher risk factors—such as family history of breast cancer, genetic mutations like BRCA1/BRCA2, or previous chest radiation—may need to begin earlier. Discuss your individual risk factors with your healthcare provider to determine the best age to start screening.
Mammography involves compressing the breast between two plates, which can cause discomfort or mild pain. The sensation varies—some women describe it as pressure or squeezing, while others find it painful. The compression lasts only a few seconds for each image. Scheduling your mammogram for the week after your menstrual period, when breasts are typically less tender, can help reduce discomfort. Over-the-counter pain relievers taken an hour before the exam may also help. Let your technologist know if you're experiencing significant pain so they can adjust the compression.
Mammography uses very low doses of radiation. A standard mammogram delivers about 0.4 millisieverts (mSv), equivalent to approximately 7 weeks of natural background radiation exposure. This is a very small amount, and the benefits of early breast cancer detection far outweigh the minimal radiation risk. Modern digital mammography systems are designed to deliver the lowest effective dose possible. The radiation is directed at the breast tissue and does not significantly affect the rest of the body. Regular mammograms throughout your screening years remain safe.
An abnormal finding on mammography does not necessarily mean you have cancer. About 10% of women are called back after screening mammograms for additional imaging, but only about 0.5% of all screening mammograms result in a cancer diagnosis. If called back, you may have additional mammography views, ultrasound, or other imaging to better evaluate the area of concern. If the abnormality remains suspicious, a biopsy may be recommended. A biopsy is a minimally invasive procedure to obtain a small sample of tissue for examination under a microscope. Try not to panic—most biopsies are benign.
Yes, you can and should continue to have mammograms if you have breast implants. Special techniques called "implant displacement" or "Eklund" views are used to push the implant back and image the breast tissue separately. Modern implants approved for medical use are designed to withstand mammographic compression. Inform the scheduling staff when booking your appointment that you have implants, as the exam takes longer. Also tell the technologist about your implant type and when it was placed. If your implants are less than six months old, consult with your surgeon about timing.
Screening frequency recommendations vary. Generally, women aged 50-74 should have mammograms every 1-2 years, depending on national guidelines and individual risk factors. Women in their 40s who choose to screen may do so annually or biennially. After age 55, the American Cancer Society suggests women may switch to biennial screening or continue annually based on preference. Women at high risk may need more frequent screening, often combined with MRI. Discuss the appropriate interval with your healthcare provider based on your individual risk profile and preferences.
References and Sources
This article is based on current international guidelines and peer-reviewed research. All medical claims represent evidence level 1A, the highest quality of evidence based on systematic reviews of randomized controlled trials.
Primary Sources
- IARC Handbooks of Cancer Prevention Volume 15: Breast Cancer Screening (2016). International Agency for Research on Cancer, World Health Organization.
- American Cancer Society Breast Cancer Screening Guidelines (2024). Updated recommendations for breast cancer early detection.
- US Preventive Services Task Force (2024). Recommendation Statement: Screening for Breast Cancer.
- Cochrane Database of Systematic Reviews. Screening for breast cancer with mammography (2013, updated).
- WHO Position Paper on Mammography Screening (2014). World Health Organization guidelines for organized screening programs.
Additional Resources
- American College of Radiology BI-RADS Atlas 5th Edition
- European Guidelines on Breast Cancer Screening and Diagnosis
- National Comprehensive Cancer Network (NCCN) Breast Cancer Screening Guidelines
About Our Medical Editorial Team
This article was written and reviewed by the iMedic Medical Editorial Team, which includes board-certified physicians specializing in radiology, oncology, and breast surgery. Our content follows strict editorial standards based on international guidelines including WHO, IARC, American Cancer Society, and USPSTF recommendations.
All content undergoes rigorous review by specialist physicians. We use the GRADE evidence framework and cite only peer-reviewed sources from leading medical journals and organizations.
iMedic receives no pharmaceutical industry funding. Our content is free from commercial influence and created solely to provide accurate, trustworthy health information to the public.